![Tom Strange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Strange
Inversor de Capital Privado en
iCON Infrastructure LLP
.
Perfil
Tom Shaw Le Strange is currently a Director at iCON Infrastructure LLP.
Previously, he was a Director at MiroBio Ltd. in 2022.
He graduated from the University of Cambridge in 2012 and completed his undergraduate degree at The University of Nottingham in 2008.
Cargos activos de Tom Strange
| Empresas | Cargo | Inicio |
|---|---|---|
iCON Infrastructure LLP
 iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure invests in mid-market companies across Europe and North America. The firm targets companies operating in the fields of transportation, utilities, telecommunication, energy & environment and social infrastructure sectors. It provides financing for buyout transactions. | Inversor de Capital Privado | 01/06/2023 |
Antiguos cargos conocidos de Tom Strange.
| Empresas | Cargo | Fin |
|---|---|---|
MiroBio Ltd.
 MiroBio Ltd. BiotechnologyHealth Technology Develops therapeutics for auto-immune diseases | Inversor de Capital Privado | 01/11/2022 |
Formación de Tom Strange.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
98
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iCON Infrastructure LLP
iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure invests in mid-market companies across Europe and North America. The firm targets companies operating in the fields of transportation, utilities, telecommunication, energy & environment and social infrastructure sectors. It provides financing for buyout transactions. | Finance |
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Develops therapeutics for auto-immune diseases | Health Technology |
- Bolsa de valores
- Insiders
- Tom Strange
